Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

NR Fillmore, J La, JTY Wu, JK Corrigan… - Blood …, 2023 - ashpublications.org
COI notes: NF reported receiving grants from the American Heart Association (857078).
WBE reported receiving research grants (site PI for multicenter study) from Gilead Sciences …

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

J La, JTY Wu, W Branch-Elliman… - Blood, The Journal …, 2022 - ashpublications.org
COI notes: Dr Branch-Elliman reported receiving grants (site PI for multicenter study) from
Gilead Sciences and funds to institution and grants from VA Health Services Research and …

[HTML][HTML] From Hematologistʼs desk: The effect of COVID‐19 on the blood system

KK Sahu, AD Siddiqui - American Journal of Hematology, 2020 - ncbi.nlm.nih.gov
1. Barnes BJ, Adrover JM, Baxter-Stoltzfus A. Targeting potential drivers of COVID-19:
Neutrophil extracellular traps. J Exp Med. 2020; 217 (6): e20200652. https://doi …

Covid‐19 will not “magically disappear”: Why access to widespread testing is paramount

PE George, CL Stokes, LC Bassit… - American Journal of …, 2021 - Wiley Online Library
Since the beginning of the current pandemic, Covid-19 has infiltrated all aspects of
biomedicine. As the associations between mortality risk and chronic illness became evident …

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

Y Zhou, R Shalhoub, SN Rogers, S Yu… - Blood, The Journal …, 2022 - ashpublications.org
COI notes: GSV is a consultant with STRM. BIO and receives research grant from
AstraZeneca. During 2021, T Gniadek was a paid consultant for Frenwal/Fresenius Kabi and …

[HTML][HTML] Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course

V Petzer, S Schwendinger, D Haschka… - American Journal of …, 2021 - ncbi.nlm.nih.gov
To the Editor: The strength of host immune reaction to infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) determines the severity of corona virus disease …

Blood bans and COVID-19: Government attempts to influence medicine and science threaten us all

JW Jacobs, TC Binns, DM Chooljian… - American journal of …, 2023 - academic.oup.com
Every 2 seconds someone in the United States needs blood or platelets. With nearly 16
million blood products transfused each year, blood transfusion is one of the most common …

Hematologic parameters in patients with COVID-19 infection.

BE Fan, VCL Chong, SSW Chan, GH Lim… - American journal of …, 2020 - europepmc.org
A comment on this article appears in" Isolated erythrocytosis: A consequence of COVID-19
induced hypoxia." Int J Lab Hematol. 2022 Feb; 44 (1): e44-e45. This article has been …

[HTML][HTML] Immunologic characterization of COVID-19 patients with hematological cancer

C Maia, E Martín-Sánchez, JJ Garcés… - …, 2021 - ncbi.nlm.nih.gov
The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic is having a
profound impact in oncologic care, 1 with recent analyses suggesting that cancer patients …

[PDF][PDF] Plasmacytoid lymphocytes in SARS‐CoV‐2 infection (Covid‐19)

D Foldes, R Hinton, S Arami, BJ Bain - American Journal of Hematology, 2020 - bsh.org.uk
A 59-year-old man with no known past medical history presented to the emergency
department with dyspnea, abdominal pain and malaise. Clinical assessment revealed …